NCT07323615

Brief Summary

This study will compare the experimental group (debridement assisted by surgical microscope + VSD) and the control group (debridement under naked-eye observation + VSD) in terms of the rate of change in BWAT scores at one week postoperatively when the VSD is removed, daily wound negative-pressure drainage volume and pain scores within the first postoperative week, and results of two wound bacterial cultures. The study aims to scientifically evaluate the difference in efficacy between microscope-assisted debridement and naked-eye debridement, with the goal of providing a reference for the clinical debridement treatment of skin wounds.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Dec 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Dec 2025Jan 2027

First Submitted

Initial submission to the registry

December 10, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

December 16, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 10, 2025

Last Update Submit

December 23, 2025

Conditions

Keywords

skin woundinfectiondebridementmicroscopetherapeutic effect

Outcome Measures

Primary Outcomes (1)

  • To compare the rate of change in wound scores between two methods of skin wound debridement.

    the rate of change in wound scores= (BWAT score at 1-week post-debridement (VSD removal) - Pre-debridement BWAT score) / Pre-debridement BWAT score. The Bates-Jensen Wound Assessment Tool (BWAT) is a comprehensive, standardized instrument designed for the detailed assessment and documentation of wound characteristics. It is widely used by healthcare professionals, particularly in wound care, dermatology, and long-term care settings, to evaluate a variety of chronic wounds, including pressure injuries, venous stasis ulcers, diabetic foot ulcers, and surgical wounds. The strength of the BWAT lies in its structured approach. It assesses 13 key wound characteristics, each characteristic is scored from 1-5. The HIGHER the total score(13-65), the more severe the wound status.

    one week

Secondary Outcomes (4)

  • To compare the daily volume of wound negative pressure drainage between the two groups within one week postoperatively

    one week

  • To compare the daily pain scores of patients between the two groups within one week postoperatively

    one week

  • To compare the rate of conversion from positive to negative in wound bacterial culture between the two groups at one week postoperatively

    two weeks

  • To compare the length of hospital stay between the two groups

    through study completion, an average of 1 month

Study Arms (2)

naked-eye

NO INTERVENTION

Debridement under naked-eye observation plus Vacuum Sealing Drainage (VSD)

microscopic

EXPERIMENTAL

Debridement under microscopic magnification assistance plus Vacuum Sealing Drainage (VSD).

Device: microscopic

Interventions

debridement with surgical microscope

microscopic

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients aged ≥18 years
  • Patients with chronic skin wounds requiring surgical debridement due to causes such as trauma, diabetes, venous ulcers, or pressure injuries
  • Patients whose systemic underlying medical conditions permit surgical tolerance
  • Patients who agree to participate in the clinical study and provide signed informed consent

You may not qualify if:

  • Presence of severe systemic immune diseases
  • Known allergy to any component of the Vacuum Sealing Drainage (VSD) dressing
  • Wounds with uncontrollable active major hemorrhage
  • Visible bone fragments or internal fixation materials within the wound
  • Pregnancy or lactation
  • Inability to cooperate with or complete follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infections

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Debridement under microscopic magnification assistance plus Vacuum Sealing Drainage (VSD).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Director for Administration, Trauma Center

Study Record Dates

First Submitted

December 10, 2025

First Posted

January 7, 2026

Study Start

December 16, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 31, 2027

Last Updated

January 7, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

individual participant data, as well as the study protocol, statistical analysis plan, and clinical study report.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Sharing will begin within 6 months after the publication of the main study results in a peer-reviewed journal, last for 5 years.
Access Criteria
Data will be made available to qualified researchers whose study proposals have been approved by an independent Data Access Committee for the purpose of independent verification or secondary meta-analysis.